These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38849915)

  • 1. A proposed analytical framework for qualitative evaluation of access to medicines from a health systems perspective.
    Joosse IR; van den Ham HA; Mantel-Teeuwisse AK; Suleman F
    BMC Res Notes; 2024 Jun; 17(1):159. PubMed ID: 38849915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of promoting access to medicines in China - problems and recommendations.
    Sun J; Hu CJ; Stuntz M; Hogerzeil H; Liu Y
    BMC Health Serv Res; 2018 Feb; 18(1):125. PubMed ID: 29458428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines: a case of Ghana.
    Koduah A
    Front Public Health; 2023; 11():1163342. PubMed ID: 37483923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of access to childhood cancer medicines: a comparative, mixed-methods analysis of four Caribbean countries.
    Boateng R; Petricca K; Tang B; Parikh S; SinQuee-Brown C; Alexis C; Browne-Farmer C; Reece-Mills M; Salmon SM; Bodkyn C; Gupta S; Maguire B; Denburg AE
    Lancet Glob Health; 2021 Sep; 9(9):e1314-e1324. PubMed ID: 34416215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyzing implementation dynamics using theory-driven evaluation principles: lessons learnt from a South African centralized chronic dispensing model.
    Magadzire BP; Marchal B; Mathys T; Laing RO; Ward K
    BMC Health Serv Res; 2017 Dec; 17(Suppl 2):724. PubMed ID: 29219098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to childhood cancer medicines in South Africa: a health systems analysis of barriers and enablers.
    Joosse IR; van den Ham HA; Mantel-Teeuwisse AK; Perumal-Pillay VA; Suleman F
    J Pharm Policy Pract; 2024; 17(1):2372033. PubMed ID: 39011354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to medicines from a health system perspective.
    Bigdeli M; Jacobs B; Tomson G; Laing R; Ghaffar A; Dujardin B; Van Damme W
    Health Policy Plan; 2013 Oct; 28(7):692-704. PubMed ID: 23174879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supply chain management of health commodities for reducing global disease burden.
    Chukwu OA; Ezeanochikwa VN; Eya BE
    Res Social Adm Pharm; 2017; 13(4):871-874. PubMed ID: 27720436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to essential drugs in Guyana: a public health challenge.
    Seoane-Vazquez E; Rodriguez-Monguio R
    Int J Health Plann Manage; 2010; 25(1):2-16. PubMed ID: 18536003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives.
    Kaló Z; Petykó ZI; Fricke FU; Maniadakis N; Tesař T; Podrazilová K; Espin J; Inotai A
    Cost Eff Resour Alloc; 2021 Jul; 19(1):42. PubMed ID: 34266465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential Medicines in Universal Health Coverage: A Scoping Review of Public Health Law Interventions and How They Are Measured in Five Middle-Income Countries.
    Perehudoff K; Demchenko I; Alexandrov NV; Brutsaert D; Ackon A; Durán CE; El-Dahiyat F; Hafidz F; Haque R; Hussain R; Salenga R; Suleman F; Babar ZU
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33353250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review.
    Babar ZU; Gammie T; Seyfoddin A; Hasan SS; Curley LE
    Res Social Adm Pharm; 2019 Mar; 15(3):231-243. PubMed ID: 29678413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
    Coghlan R; Stephens P; Mwale B; Siyanga M
    Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of Kenya's cancer policies to improve access to cancer testing and treatment in the country.
    Makau-Barasa LK; Greene S; Othieno-Abinya NA; Wheeler SB; Skinner A; Bennett AV
    Health Res Policy Syst; 2020 Jan; 18(1):2. PubMed ID: 31910868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Access to Medicines for Rare Diseases in European Countries.
    Detiček A; Locatelli I; Kos M
    Value Health; 2018 May; 21(5):553-560. PubMed ID: 29753352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status.
    Maniadakis N; Kourlaba G; Shen J; Holtorf A
    BMC Health Serv Res; 2017 May; 17(1):371. PubMed ID: 28545440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to cancer medication in public hospitals in a middle-income country: The view of stakeholder.
    Moye-Holz D; Dreser A; van Dijk JP; Reijneveld SA; Hogerzeil HV
    Res Social Adm Pharm; 2020 Sep; 16(9):1255-1263. PubMed ID: 31796333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alignment in the registration, selection, procurement and reimbursement of essential medicines for childhood cancers in South Africa.
    Joosse IR; van den Ham HA; Mantel-Teeuwisse AK; Suleman F
    BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37730243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inefficient procurement processes undermine access to medicines in the Western Cape Province of South Africa.
    Magadzire BP; Ward K; Leng HMJ; Sanders D
    S Afr Med J; 2017 Jun; 107(7):581-584. PubMed ID: 29025446
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.